Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate

Carcinogenesis

Volumn 32, Issue 2, 2011, Pages 233-239

  Cheungy, Connie ^a   Loyy, Shea ^a   Li, Guang Xun ^a   Liu, Anna B ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 2; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DEXTRAN SULFATE; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CHEMICAL CARCINOGENESIS; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENOTYPE; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; SURVIVAL RATE; TRANSGENE; WESTERN BLOTTING; WILD TYPE;

EID: 79251535331     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq235     Document Type: Article

References (46)

1. American Cancer Society. (2010) Cancer Facts and Figures, 2010. American Cancer Society, Atlanta, GA.
2. Gerhardsson de Verdier, M. et al. (1991) Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int. J. Cancer, 49, 520-525.
3. Schiffman, M.H. et al. (1990) Re: "Fried foods and the risk of colon cancer". Am. J. Epidemiol., 131, 376-378.
4. Cross, A.J. et al. (2010) A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res., 70, 2406-2414.
5. Wakabayashi, K. et al. (1993) Exposure to heterocyclic amines. Environ. Health Perspect., 99, 129-134.
6. Augustsson, K. et al. (1997) Assessment of the human exposure to heterocyclic amines. Carcinogenesis, 18, 1931-1935.
7. Butler, M.A. et al. (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl Acad. Sci. USA, 86, 7696-7700.
8. Hammons, G.J. et al. (1997) Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis, 18, 851-854.
9. Crofts, F.G. et al. (1998) Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis, 19, 1969-1973.
10. Kaderlik, K.R. et al. (1994) Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis, 15, 1695-1701.
11. Kaderlik, K.R. et al. (1994) Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis, 15, 1703-1709.
12. Turesky, R.J. et al. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
13. Chou, H.C. et al. (1995) Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res., 55, 525-529.
14. Lang, N.P. et al. (1994) Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev., 3, 675-682.
15. Le Marchand, L. et al. (2001) Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 1259-1266.
16. Ochiai, M. et al. (1996) Efficient method for rapid induction of aberrant crypt foci in rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res., 87, 1029-1033.
17. Bird, R.P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151.
18. Ubagai, T. et al. (2002) Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet. Carcinogenesis, 23, 197-200.
19. Nakagama, H. et al. (2002) A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP. Mutat. Res., 506-507, 137-144.
20. Esumi, H. et al. (1989) Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res., 80, 1176-1178.
21. Kristiansen, E. et al. (1998) Effects of long-term feeding with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in C57BL/ByA and E mupim-1 mice. Cancer Lett., 122, 215-220.
22. Ochiai, M. et al. (2002) Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res., 93, 478-483.
23. Tanaka, T. et al. (2005) Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis, 26, 229-238.
24. Nishikawa, A. et al. (2005) Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. Toxicol. Sci., 84, 243-248.
25. Nakanishi, M. et al. (2007) Mouse strain differences in inflammatory responses of colonic mucosa induced by dextran sulfate sodium cause differential susceptibility to PhIP-induced large bowel carcinogenesis. Cancer Sci., 98, 1157-1163.
26. Okayasu, I. et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology, 98, 694-702.
27. Lin, D.X. et al. (1995) Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Dispos., 23, 518-524.
28. Turteltaub, K.W. et al. (1999) Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses. Cancer Lett., 143, 149-155.
29. Cheung, C. et al. (2008) Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment. J. Pharmacol. Exp. Ther., 327, 288-299.
30. Cheung, C. et al. (2005) Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem. Res. Toxicol., 18, 1471-1478.
31. Jiang, Z. et al. (2005) Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BACtransgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum. Mutat., 25, 196-206.
32. Dragin, N. et al. (2007) Generation of 'humanized' hCYP1A1_1A2_ Cyp1a1/1a2(-/-) mouse line. Biochem. Biophys. Res. Commun., 359, 635-642.
33. Hao, X.P. et al. (2001) Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res., 61, 8085-8088.
34. Tsukamoto, T. et al. (2000) More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats. Jpn. J. Cancer Res., 91, 792-796.
35. Miller, J.R. et al. (1996) Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev., 10, 2527-2539.
36. Markowitz, S.D. et al. (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med., 361, 2449-2460.
37. Schneikert, J. et al. (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut, 56, 417-425.
38. Arber, N. et al. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110, 669-674.
39. Sparks, A.B. et al. (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
40. Iwamoto, M. et al. (2000) Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis, 21, 1935-1940.
41. Lala, P.K. et al. (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol., 2, 149-156.
42. Bostwick, D.G. et al. (2004) High-grade prostatic intraepithelial neoplasia. Mod. Pathol., 17, 360-379.
43. Borowsky, A.D. et al. (2006) Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia, 8, 708-715.
44. Erdelyi, I. et al. (2009) Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J. Nutr., 139, 2072-2078.
45. Weisburger, J.H. et al. (1994) The role of fat and calcium in the production of foci of aberrant crypts in the colon of rats fed 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine. Environ. Health Perspect., 102 (suppl. 6)), 53-55.
46. Wang, R. et al. (2008) Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and beta-catenin expression in the rat. Carcinogenesis, 29, 834-839.